Large-scale testing (Phase 3)UnknownNCT01352091What this trial is testingAdjuvant AI Combined With ZoladexWho this might be right forBreast Cancer Fudan University 670
Testing effectiveness (Phase 2)UnknownNCT01266213What this trial is testingFulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal WomenWho this might be right forMetastatic Breast CancerEstrogen Receptor Positive TumorBreast Cancer Nos Premenopausal Samsung Medical Center 147
Testing effectiveness (Phase 2)Looking for participantsNCT07159451What this trial is testingA Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast CancerWho this might be right forBreast Cancer Gustave Roussy, Cancer Campus, Grand Paris 140
Not applicableUnknownNCT04891731What this trial is testingEfficacy and Safety of Leuprorelin 3M in Premenopausal Women With Hormone Receptor-positive Breast CancerWho this might be right forHormone Receptor-positive Breast Cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 120
Not applicableActive Not RecruitingNCT03448003What this trial is testingComprehensive Lifestyle Change To Prevent Breast CancerWho this might be right forPremenopausal M.D. Anderson Cancer Center 60
Large-scale testing (Phase 3)UnknownNCT04753177What this trial is testingThe Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast CancerWho this might be right forThe Neoadjuvant Therapy Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary 120
Large-scale testing (Phase 3)Study completedNCT00311636What this trial is testingTriptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By SurgeryWho this might be right forBreast Cancer Gruppo Italiano Mammella (GIM) 280
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07287098What this trial is testingImlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast CancerWho this might be right forBreast Neoplasms Eli Lilly and Company 600
Large-scale testing (Phase 3)Study completedNCT06009627What this trial is testingStudy of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer PatientsWho this might be right forBreast Cancer Tianjin Medical University Cancer Institute and Hospital 119
Not applicableUnknownNCT03582865What this trial is testingGenetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of TamoxifenWho this might be right forBreast Cancer Assiut University 100
Early research (Phase 1)UnknownNCT04660929What this trial is testingCAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsWho this might be right forHER2-positiveAdenocarcinomaBile Duct Cancer+28 more Carisma Therapeutics Inc 48
Not applicableLooking for participantsNCT00823654What this trial is testingSerum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA MutationsWho this might be right forBreast Cancer Memorial Sloan Kettering Cancer Center 609
Post-approval studies (Phase 4)Study completedNCT02344940What this trial is testingSafety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast CancerWho this might be right forBreast Cancer Shanghai Jiao Tong University School of Medicine 104
Large-scale testing (Phase 3)Study completedNCT02525159What this trial is testingEffectiveness of DIM Supplements to Increase 2-OHE1/16 RatioWho this might be right forBreast Cancer Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes 60
Testing effectiveness (Phase 2)Study completedNCT04659551What this trial is testingNeoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer PatientsWho this might be right forBreast Cancer Istituto Oncologico Veneto IRCCS 43
Large-scale testing (Phase 3)UnknownNCT02132000What this trial is testingEfficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer PatientsWho this might be right forBreast Cancer Patients in PremenopausalEstrogen and/or Progesterone Receptor Positive Fengxi Su 3,036
Testing effectiveness (Phase 2)Study completedNCT05896566What this trial is testingA Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast CancerWho this might be right forBreast Cancer ETOP IBCSG Partners Foundation 231
Large-scale testing (Phase 3)Study completedNCT00659373What this trial is testingBrain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02Who this might be right forBreast CancerFatigueSleep Disorders ETOP IBCSG Partners Foundation 86
Post-approval studies (Phase 4)Study completedNCT00999921What this trial is testingEffects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast CancerWho this might be right forBenign Breast DiseaseFibrocystic Disease of BreastFibroadenoma+1 more Medical College and Hospital Kolkata 256
Large-scale testing (Phase 3)Active Not RecruitingNCT01905046What this trial is testingMetformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast CancerWho this might be right forAtypical Ductal Breast HyperplasiaBRCA1 Mutation CarrierBRCA2 Mutation Carrier+2 more Alliance for Clinical Trials in Oncology 86